WuXi STA Changzhou Site Passes First U.S. FDA Inspection
The integrated R&D and manufacturing facility is expecting more products to go into commercial production post approval SHANGHAI, May 7, 2018 /PRNewswire/ — STA Pharmaceutical Co., Ltd., (WuXi STA), a…